Our oral formulation researchers are responsible for identifying new,
innovative oral drug delivery systems for the oral drug project
portfolio. Specifically, they formulate therapeutic peptides and
proteins into orally available products, such as tablets.
They are also responsible for solid-state characterisation and
analysis of both drug product intermediates and the final drug product.
Formulation researchers work very early in the R&D value chain.
They perform early research activities, identify oral formulations for
our therapeutic peptides and proteins, and find compositions and
processes by which these formulations can be made.
Once a suitable formulation has been identified, tested, and found
to fulfil the given target product profile, the composition and
process are transferred to CMC Development, where the formulation will
be further upscaled and manufactured for clinical trials.